Breaking News

9 Pharmaceutical Companies Enter Agreement with Trump to Lower Medicine Costs

Amgen, BMS, Boehringer Ingelheim, GSK and more agree to lower the cost of medicines for Americans in line with the lowest prices paid by other developed nations.

Author Image

By: Charlie Sternberg

Associate Editor

Nine leading global pharmaceutical companies announced broad agreements with the Trump administration on Friday to lower the cost of medicines for American patients in line with the lowest prices paid by other developed nations (known as the most-favored-nation, or MFN, price). This includes participating in a direct purchasing platform, TrumpRx.gov, that will allow American patients to purchase medicines at a significant discount. The nine manufacturers include: Amgen Bristol Myers Sq...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters